315 related articles for article (PubMed ID: 24597568)
1. Dorsal hippocampal NMDA receptor blockade impairs extinction of naloxone-precipitated conditioned place aversion in acute morphine-treated rats by suppressing ERK and CREB phosphorylation in the basolateral amygdala.
Wang WS; Chen ZG; Liu WT; Chi ZQ; He L; Liu JG
Br J Pharmacol; 2015 Jan; 172(2):482-91. PubMed ID: 24597568
[TBL] [Abstract][Full Text] [Related]
2. Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex.
Wang WS; Kang S; Liu WT; Li M; Liu Y; Yu C; Chen J; Chi ZQ; He L; Liu JG
J Neurosci; 2012 Oct; 32(40):13763-75. PubMed ID: 23035088
[TBL] [Abstract][Full Text] [Related]
3. Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving.
Li YQ; Li FQ; Wang XY; Wu P; Zhao M; Xu CM; Shaham Y; Lu L
J Neurosci; 2008 Dec; 28(49):13248-57. PubMed ID: 19052216
[TBL] [Abstract][Full Text] [Related]
4. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
[TBL] [Abstract][Full Text] [Related]
5. Conditioned aversive memory associated with morphine withdrawal increases brain-derived neurotrophic factor in dentate gyrus and basolateral amygdala.
Martínez-Laorden E; Navarro-Zaragoza J; Milanés MV; Laorden ML; Almela P
Addict Biol; 2020 Jul; 25(4):e12792. PubMed ID: 31282111
[TBL] [Abstract][Full Text] [Related]
6. Interactions between prelimbic cortex and basolateral amygdala contribute to morphine-induced conditioned taste aversion in conditioning and extinction.
Huang ACW; Yu YH; He ABH; Ou CY
Neurobiol Learn Mem; 2020 Jul; 172():107248. PubMed ID: 32407964
[TBL] [Abstract][Full Text] [Related]
7. Opiate exposure state controls dopamine D3 receptor and cdk5/calcineurin signaling in the basolateral amygdala during reward and withdrawal aversion memory formation.
Rosen LG; Rushlow WJ; Laviolette SR
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):59-66. PubMed ID: 28627448
[TBL] [Abstract][Full Text] [Related]
8. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens.
Ahmad T; Sun N; Lyons D; Laviolette SR
Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
10. Extinction of conditioned opiate withdrawal in rats is blocked by intracerebroventricular infusion of an NMDA receptor antagonist.
Coleman BR; Carlezon WA; Myers KM
Neurosci Lett; 2013 Apr; 541():39-42. PubMed ID: 23416323
[TBL] [Abstract][Full Text] [Related]
11. NAc Shell Arc/Arg3.1 Protein Mediates Reconsolidation of Morphine CPP by Increased GluR1 Cell Surface Expression: Activation of ERK-Coupled CREB is Required.
Lv XF; Sun LL; Cui CL; Han JS
Int J Neuropsychopharmacol; 2015 Mar; 18(9):. PubMed ID: 25746394
[TBL] [Abstract][Full Text] [Related]
12. NMDA receptors in the basolateral amygdala mediate acquisition and extinction of an amphetamine conditioned place preference.
Goodman J; Hsu E; Packard MG
Behav Neurosci; 2019 Aug; 133(4):428-436. PubMed ID: 31294591
[TBL] [Abstract][Full Text] [Related]
13. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
Navarro-Zaragoza J; Laorden ML; Milanés MV
Addict Biol; 2017 Mar; 22(2):342-353. PubMed ID: 26598419
[TBL] [Abstract][Full Text] [Related]
15. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
[TBL] [Abstract][Full Text] [Related]
16. D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats.
Myers KM; Carlezon WA
Biol Psychiatry; 2010 Jan; 67(1):85-7. PubMed ID: 19782965
[TBL] [Abstract][Full Text] [Related]
17. Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats.
Cao JL; He JH; Ding HL; Zeng YM
Pain; 2005 Dec; 118(3):336-349. PubMed ID: 16289800
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms in hippocampus and basolateral amygdala but not in parietal or cingulate cortex are involved in extinction of one-trial avoidance learning.
Myskiw JC; Fiorenza NG; Izquierdo LA; Izquierdo I
Neurobiol Learn Mem; 2010 Sep; 94(2):285-91. PubMed ID: 20601026
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glutamatergic transmission by morphine in the basolateral amygdaloid nucleus reduces pain-induced aversion.
Deyama S; Yamamoto J; Machida T; Tanimoto S; Nakagawa T; Kaneko S; Satoh M; Minami M
Neurosci Res; 2007 Oct; 59(2):199-204. PubMed ID: 17675178
[TBL] [Abstract][Full Text] [Related]
20. Glutamate receptors in the dorsal hippocampus mediate the acquisition, but not the expression, of conditioned place aversion induced by acute morphine withdrawal in rats.
Hou YY; Liu Y; Kang S; Yu C; Chi ZQ; Liu JG
Acta Pharmacol Sin; 2009 Oct; 30(10):1385-91. PubMed ID: 19767765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
